Skip to main content
AAN.com
Articles
May 23, 2011

Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia

May 24, 2011 issue
76 (21) 1804-1810

Abstract

Objectives:

To examine the longitudinal course of primary progressive aphasia (PPA) over a 2-year period and to offer quantitative ranges of expected change that could be used to guide the design and evaluation of therapeutic intervention trials.

Methods:

Regional changes of cortical thickness and whole-brain cortical volume loss as well as neuropsychological language performance were assessed at baseline and 2 years later in 13 rigorously characterized patients who fulfilled research criteria for logopenic, agrammatic, and semantic PPA subtypes (6 PPA-L, 3 PPA-G, and 4 PPA-S).

Results:

There was substantial progression of clinical deficits and cortical atrophy over 2 years. Neuropsychological language performance patterns lost the sharp distinctions that differentiated one PPA variant from another. Nonetheless, the subtype-specific differential impairment of word comprehension vs grammatical processing was largely maintained. Peak atrophy sites spread beyond the initial distinctive locations that characterized each of the 3 subtypes and displayed a more convergent distribution encompassing all 3 major components of the language network: the inferior frontal gyrus, the temporoparietal junction, and lateral temporal cortex. Despite the progression, overall peak atrophy remained lateralized to the left hemisphere.

Conclusions:

The results suggest that the unique features, which sharply differentiate the PPA variants at the early to middle stages, may lose their distinctiveness as the degeneration becomes more severe. Given the substantial atrophy over 2 years, PPA clinical trials may require fewer patients and shorter study durations than Alzheimer disease trials to detect significant therapeutic effects.

Get full access to this article

View all available purchase options and get full access to this article.

REFERENCES

1.
Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335–346.
2.
Knopman DS, Jack CR, Kramer JH, et al. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology 2009;72:1843–1849.
3.
Mesulam MM. Primary progressive aphasia: a language-based dementia. N Engl J Med 2003;349:1535–1542.
4.
Mesulam M, Weintraub S. Primary progressive aphasia and kindred disorders. Handb Clin Neurol 2008;89:573–587.
5.
Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Recommendations for the classification of primary progressive aphasia and its variants. Neurology 2011;76:1006–1014.
6.
Weintraub S, Mesulam MM, Wieneke C, Rademaker A, Rogalski EJ, Thompson CK. The Northwestern Anagram Test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Dement 2009;24:408–416.
7.
Dunn L, Dunn D. Peabody Picture Vocabulary Test. Toronto: Pearson Canada Assessment Inc.; 2006.
8.
Mesulam M, Wieneke C, Rogalski E, Cobia D, Thompson C, Weintraub S. Quantitative template for subtyping primary progressive aphasia. Arch Neurol 2009;66:1545–1551.
9.
Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea and Febiger; 1983.
10.
Sapolsky D, Bakkour A, Negreira A, et al. Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia. Neurology 2010;75:358–366.
11.
Mesulam M, Wicklund A, Johnson N, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 2008;63:709–719.
12.
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050–11055.
13.
Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968–980.
14.
Buckner RL, Head D, Parker J, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: Reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004;23:724–738.
15.
Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15:870–878.
16.
Jack CR, Shiung MM, Gunter JL, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004;62:591–600.
17.
Brambati SM, Rankin KP, Narvid J, et al. Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neurobiol Aging 2009;30:103–111.
18.
Avants B, Anderson C, Grossman M, Gee JC. Spatiotemporal normalization for longitudinal analysis of gray matter atrophy in frontotemporal dementia. Med Image Comput Comput Assist Interv 2007;10:303–310.
19.
Wicklund AH, Rademaker A, Johnson N, Weitner BB, Weintraub S. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes. Alzheimer Dis Assoc Disord 2007;21:S70–S78.
20.
Blair M, Marczinski CA, Davis-Faroque N, Kertesz A. A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc 2007;13:237–245.
21.
Weintraub S, Rubin NP, Mesulam MM. Primary progressive aphasia: longitudinal course, neuropsychological profile, and language features. Arch Neurol 1990;47:1329–1335.
22.
Libon DJ, Xie SX, Wang X, et al. Neuropsychological decline in frontotemporal lobar degeneration: a longitudinal analysis. Neuropsychology 2009;23:337–346.

Information & Authors

Information

Published In

Neurology®
Volume 76Number 21May 24, 2011
Pages: 1804-1810
PubMed: 21606451

Publication History

Received: December 1, 2010
Accepted: February 10, 2011
Published online: May 23, 2011
Published in print: May 24, 2011

Permissions

Request permissions for this article.

Disclosure

Dr. Rogalski receives research support from the NIH (NIA, NIDCD). Dr. Cobia receives research support from the NIH (NIA, NIDCD). T.M. Harrison reports no disclosures. C. Wieneke receives research support from the NIH/NIDCD. Dr. Weintraub serves on the editorial boards of Alzheimer's and Dementia, the Turkish Journal of Neurology, Dementia & Neuropsychologia, and the Journal of the Brazilian Academy of Neurology; and receives research support from the NIH (NIA, NIDCD). Dr. Mesulam serves on the scientific advisory boards for the Cure Alzheimer Fund and the Association on Frontotemporal Dementia; serves on the editorial boards of Brain, Annals of Neurology, Human Brain Mapping, and Journal of Cognitive Neuroscience; receives royalties from the publication of Principles of Behavioral and Cognitive Neurology (Oxford University Press, 2000); and receives research support from the NIH (NIDCD, NIA).

Authors

Affiliations & Disclosures

E. Rogalski, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (E.R., T.M.H., C.W., S.W., M.-M.M.), Department of Psychiatry and Behavioral Sciences (D.C., S.W.), and Department of Neurology (M.-M.M.), Northwestern University Feinberg School of Medicine, Chicago, IL.
D. Cobia, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (E.R., T.M.H., C.W., S.W., M.-M.M.), Department of Psychiatry and Behavioral Sciences (D.C., S.W.), and Department of Neurology (M.-M.M.), Northwestern University Feinberg School of Medicine, Chicago, IL.
T.M. Harrison, BS
From the Cognitive Neurology and Alzheimer's Disease Center (E.R., T.M.H., C.W., S.W., M.-M.M.), Department of Psychiatry and Behavioral Sciences (D.C., S.W.), and Department of Neurology (M.-M.M.), Northwestern University Feinberg School of Medicine, Chicago, IL.
C. Wieneke, BA
From the Cognitive Neurology and Alzheimer's Disease Center (E.R., T.M.H., C.W., S.W., M.-M.M.), Department of Psychiatry and Behavioral Sciences (D.C., S.W.), and Department of Neurology (M.-M.M.), Northwestern University Feinberg School of Medicine, Chicago, IL.
S. Weintraub, PhD
From the Cognitive Neurology and Alzheimer's Disease Center (E.R., T.M.H., C.W., S.W., M.-M.M.), Department of Psychiatry and Behavioral Sciences (D.C., S.W.), and Department of Neurology (M.-M.M.), Northwestern University Feinberg School of Medicine, Chicago, IL.
M.-M. Mesulam, MD
From the Cognitive Neurology and Alzheimer's Disease Center (E.R., T.M.H., C.W., S.W., M.-M.M.), Department of Psychiatry and Behavioral Sciences (D.C., S.W.), and Department of Neurology (M.-M.M.), Northwestern University Feinberg School of Medicine, Chicago, IL.

Notes

Study funding: Supported by the NIH (NIDCD DC008552 NIA AG13854 [Alzheimer Disease Center] and NCRR 5KL2RR025740). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Imaging was performed at the Northwestern University Department of Radiology Center for Advanced MRI (CAMRI).
Address correspondence and reprint requests to Dr. Emily J. Rogalski, Northwestern University, Cognitive Neurology and Alzheimer's Disease Center (CNADC), 320 E Superior Street, Searle Building 11th Floor, Chicago, IL 60611 [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Primary Progressive Aphasia: Variants and Main Language Domains, Annals of Clinical and Experimental Neurology, 18, 4, (68-75), (2025).https://doi.org/10.17816/ACEN.1067
    Crossref
  2. Augmenting Verb-Naming Therapy With Neuromodulation Decelerates Language Loss in Primary Progressive Aphasia, American Journal of Speech-Language Pathology, 34, 1, (155-173), (2025).https://doi.org/10.1044/2024_AJSLP-24-00016
    Crossref
  3. Investigating changes in connected speech in nonfluent/agrammatic primary progressive aphasia following script training, Cortex, 183, (193-210), (2025).https://doi.org/10.1016/j.cortex.2024.09.019
    Crossref
  4. Aphasia: Etiology, symptomology, and treatment approaches, Encyclopedia of the Human Brain, (233-242), (2025).https://doi.org/10.1016/B978-0-12-820480-1.00079-6
    Crossref
  5. Production of Complex Sentences in the Semantic Variant of Primary Progressive Aphasia: Neuropsychological, Clinical, Neuroanatomical and Demographic Correlates, Applied Sciences, 14, 13, (5390), (2024).https://doi.org/10.3390/app14135390
    Crossref
  6. Differential diagnosis of frontotemporal dementia subtypes with explainable deep learning on structural MRI, Frontiers in Neuroscience, 18, (2024).https://doi.org/10.3389/fnins.2024.1331677
    Crossref
  7. Transdiagnostic Network Localization of Social, Language, and Motor Symptoms in Patients With Frontotemporal Lobar Degeneration, Neurology, 103, 12, (2024)./doi/10.1212/WNL.0000000000210108
    Abstract
  8. Altered neurovascular coupling in semantic variant primary progressive aphasia, Journal of Alzheimer’s Disease, 102, 3, (830-840), (2024).https://doi.org/10.1177/13872877241291245
    Crossref
  9. Impaired semantic control in the logopenic variant of primary progressive aphasia, Brain Communications, 7, 1, (2024).https://doi.org/10.1093/braincomms/fcae463
    Crossref
  10. Data-driven neuroanatomical subtypes of primary progressive aphasia, Brain, (2024).https://doi.org/10.1093/brain/awae314
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share